Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently become the focus of much discussion across healthcare channels. Biologics – often considered specialty drugs – have accounted for as much as 37% of drug spending in a single year. Read more about how Biologics and Biosimilars help fight chronic disease as well as the difference between Generics and Biosimilars.
Emerging Biosimilars and the Importance of Identifying Experienced Providers
Latest
Assets
The future of manufacturing with generative AI
Discover how Amazon Web Services (AWS) can help your...
Assets
Unlocking the full potential of RWD with insights from real-time EHR data
Timely data are critical for life sciences and healthcare...
Assets
The Benefits of Network Monitoring for Industrial Digitalization
Manufacturing is powered by thousands of connected devices, massive...
Newsletter
Don't miss
Assets
The future of manufacturing with generative AI
Discover how Amazon Web Services (AWS) can help your...
Assets
Unlocking the full potential of RWD with insights from real-time EHR data
Timely data are critical for life sciences and healthcare...
Assets
The Benefits of Network Monitoring for Industrial Digitalization
Manufacturing is powered by thousands of connected devices, massive...
The future of manufacturing with generative AI
Discover how Amazon Web Services (AWS) can help your industrial organization harness the transformative power of generative artificial intelligence (AI) to:
Develop new product designs...
Unlocking the full potential of RWD with insights from real-time EHR data
Timely data are critical for life sciences and healthcare organizations, enabling them to drive innovation while delivering the highest standard of care to patients....
The Benefits of Network Monitoring for Industrial Digitalization
Manufacturing is powered by thousands of connected devices, massive computing power and artificial intelligence. These advances enable manufacturers to adopt flexible, built-to-order production methodologies...